Information Journal Paper
APA:
CopyMEISSNER, E.G.. (2016). SIMTUZUMAB TREATMENT OF ADVANCED LIVER FIBROSIS IN HIV AND HCV-INFECTED ADULTS: RESULTS OF A 6-MONTH OPEN-LABEL SAFETY TRIAL. LIVER INTERNATIONAL, -(-), 0-0. SID. https://sid.ir/paper/725940/en
Vancouver:
CopyMEISSNER E.G.. SIMTUZUMAB TREATMENT OF ADVANCED LIVER FIBROSIS IN HIV AND HCV-INFECTED ADULTS: RESULTS OF A 6-MONTH OPEN-LABEL SAFETY TRIAL. LIVER INTERNATIONAL[Internet]. 2016;-(-):0-0. Available from: https://sid.ir/paper/725940/en
IEEE:
CopyE.G. MEISSNER, “SIMTUZUMAB TREATMENT OF ADVANCED LIVER FIBROSIS IN HIV AND HCV-INFECTED ADULTS: RESULTS OF A 6-MONTH OPEN-LABEL SAFETY TRIAL,” LIVER INTERNATIONAL, vol. -, no. -, pp. 0–0, 2016, [Online]. Available: https://sid.ir/paper/725940/en